TGF‑β1 affects the renal cancer miRNome and regulates tumor cells proliferation

Karolina Hanusek1, Beata Rybicka1, Piotr Popławski1

  • 1Department of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, 01‑813 Warsaw, Poland.

Insights

Transforming growth factor-beta 1 (TGF-β1) influences renal cell carcinoma (RCC) by regulating microRNAs (miRNAs) and messenger RNAs (mRNAs). This study reveals TGF-β1

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Transforming growth factor-beta 1 (TGF-β1) is a cytokine with dual roles in cancer, potentially promoting or inhibiting tumor development.
  • Previous research indicates TGF-β1 regulates microRNAs (miRNAs) implicated in renal cell carcinoma (RCC) progression.

Purpose of the Study:

  • To investigate the comprehensive effects of TGF-β1 on the RCC miRNome.
  • To elucidate the regulatory network of miRNAs and mRNAs influenced by TGF-β1 in RCC.

Main Methods:

  • Analysis of TGF-β1's impact on the global miRNome in renal cell carcinoma.
  • Investigating the regulation of cell proliferation and oncogenic factors like ETS1 by TGF-β1.
  • Examining the expression changes of specific miRNAs (e.g., miR-30c-5p, miR-155-5p) and TGF-β1 pathway components (receptors, SMADs).

Main Results:

  • TGF-β1 modulates a complex miRNA-mRNA network crucial for RCC transformation.
  • TGF-β1 regulates RCC cell proliferation and alters the expression of oncogenes such as ETS1.
  • Specific miRNAs, including miR-30c-5p, miR-155-5p, miR-181a-5p, and miR-181b-5p, are regulated by TGF-β1.
  • A feedback loop involving TGF-β1 receptors, SMADs, and miRNAs was identified.
  • ETS1 exhibits context-dependent roles, acting as an oncogene in clear cell RCC and a tumor suppressor in papillary RCC.

Conclusions:

  • TGF-β1 significantly influences the RCC miRNome and associated mRNA networks.
  • The findings highlight a novel miRNA-mediated feedback mechanism in TGF-β1 signaling within RCC.
  • ETS1's opposing functions in different RCC subtypes underscore the complexity of TGF-β1's role in renal cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K